CERC ASIA

Our cardiovascular clinical research expertise in Asia

Created in 2016 and based in Singapore, CERC Asia is the Asian subsidiary of CERC Europe. It was established to extend the CERC model by combining scientific excellence, operational expertise and clinical leadership across the Asia-Pacific region.

Led by Laure Morsiani, CERC Asia supports sponsors and investigators in conducting high-quality cardiovascular clinical trials, with a strong understanding of local regulatory environments, investigator networks and regional specificities.

A trusted CRO in Asia

CERC Asia offers a full range of CRO services tailored to the specific needs of cardiovascular innovation in Asia:

• Clinical trial design and regulatory strategy
• Study start-up and monitoring
• Data management and statistical analysis
• CEC and DSMB coordination
• Core-lab and imaging services

Thanks to its strategic position in Singapore and its integration within the CERC global network, CERC Asia serves as a reliable link between local expertise and international standards.

Supporting clinical research and scientific leadership

Beyond operational excellence, CERC Asia contributes to:

• Strengthening academic and investigator-led initiatives in Asia
• Supporting the emergence of young clinical researchers
• Facilitating collaboration between Asian and European stakeholders

Looking to conduct cardiovascular trials in Asia with a trusted, experienced and connected CRO? 

CERC Asia is ready to support your project from concept to completion.

Discover the board